Results 1 to 10 of about 1,455,204 (312)
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries [PDF]
Nature Medicine, 2021 Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is ...
Julio S Solís Arce +2 more
exaly +3 more sources
A global survey of potential acceptance of a COVID-19 vaccine
Nature Medicine, 2020 Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine.
Jeffrey V Lazarus +2 more
exaly +2 more sources
Emerging concepts in the science of vaccine adjuvants
Nature Reviews Drug Discovery, 2021 Adjuvants are vaccine components that enhance the magnitude, breadth and durability of the immune response. Following its introduction in the 1920s, alum remained the only adjuvant licensed for human use for the next 70 years.
Bali Pulendran, Prabhu S Arunachalam
exaly +2 more sources
Nature Reviews Immunology, 2021 Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries.
John S Tregoning +2 more
exaly +2 more sources
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Nature, 2020 A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic.
Kizzmekia S Corbett +2 more
exaly +2 more sources
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
New England Journal of Medicine, 2021 Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting.
N. Dagan +9 more
semanticscholar +1 more source
MODELO DE IMPACTO EM SAÚDE PÚBLICA DA INTRODUÇÃO DE UMA VACINA HÉRPES-ZOSTER RECOMBINANTE NO BRASIL
Brazilian Journal of Infectious Diseases, 2022 Introdução: O herpes-zoster (HZ) manifesta-se normalmente em idosos ou indivíduos imunocomprometidos a partir da reativação do vírus varicela zoster latente.
Ru Han +4 more
doaj +1 more source
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
New England Journal of Medicine, 2022 Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of current ...
N. Andrews +30 more
semanticscholar +1 more source
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Vaccines, 2021 Utility of vaccine campaigns to control coronavirus 2019 disease (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and healthcare workers appears to have a decisive role in the successful ...
Malik Sallam
semanticscholar +1 more source
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
New England Journal of Medicine, 2021 Background The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation.
J. Sadoff +29 more
semanticscholar +1 more source